 |
Amyl Therapeutics
Last updated: October 06, 2024
CEO Pierre Vandepapelière
Belgium | Funding: €29.7M (+)
Website: https://www.amyltx.com/
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
Website: https://www.amyltx.com/
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
